BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32285623)

  • 1. Perampanel in brain tumor-related epilepsy: Observational pilot study.
    Maschio M; Zarabla A; Maialetti A; Giannarelli D; Koudriavtseva T; Villani V; Zannino S
    Brain Behav; 2020 Jun; 10(6):e01612. PubMed ID: 32285623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis.
    Maschio M; Pauletto G; Zarabla A; Maialetti A; Ius T; Villani V; Fabi A; Koudriavtseva T; Giannarelli D
    Int J Neurosci; 2019 Jun; 129(6):593-597. PubMed ID: 30507318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perampanel in brain tumor and SMART-syndrome related epilepsy - A single institutional experience.
    Heugenhauser J; Iglseder S; Muigg A; Kerschbaumer J; Stockhammer G; Nowosielski M; Unterberger I
    J Neurol Sci; 2021 Apr; 423():117386. PubMed ID: 33706200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study).
    Coppola A; Zarabla A; Maialetti A; Villani V; Koudriavtseva T; Russo E; Nozzolillo A; Sueri C; Belcastro V; Balestrini S; Ferlazzo E; Giannarelli D; Bilo L; Maschio M
    Front Neurol; 2020; 11():592. PubMed ID: 32695064
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Pompili A; Carapella CM
    Epileptic Disord; 2012 Dec; 14(4):388-97. PubMed ID: 23248037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot Study.
    Maschio M; Dinapoli L; Zarabla A; Maialetti A; Giannarelli D; Fabi A; Vidiri A; Cantelmi T
    Clin Neuropharmacol; 2017; 40(3):113-119. PubMed ID: 28452903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of mono- and add-on perampanel in pediatric patients with epilepsy: Experience from a single-center retrospective study.
    Li Y; Guo HL; Hu YH; Wang J; Zhang YY; Huang J; Xu J; Chen J; Lu XP; Chen F
    Epilepsia Open; 2024 Feb; 9(1):268-277. PubMed ID: 37943144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
    Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
    Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perampanel: Does it have broad-spectrum potential?
    Potschka H; Trinka E
    Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
    Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
    Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Muti P
    J Neurooncol; 2011 Aug; 104(1):205-14. PubMed ID: 21107994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electro-clinical analysis of epilepsy patients with generalized seizures on adjunctive perampanel treatment.
    Montoya Gutiérrez FJ; Díaz Román M; Cerveró Albert D
    Epilepsy Res; 2020 Sep; 165():106378. PubMed ID: 32622260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life.
    Maschio M; Dinapoli L; Sperati F; Fabi A; Pace A; Vidiri A; Muti P
    J Neurooncol; 2012 Feb; 106(3):651-6. PubMed ID: 21847705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of epilepsy in brain tumor patients.
    van der Meer PB; Taphoorn MJB; Koekkoek JAF
    Curr Opin Oncol; 2022 Nov; 34(6):685-690. PubMed ID: 35838207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved irritability, mood, and quality of life following introduction of perampanel as late adjunctive treatment for epilepsy.
    Moraes JS; Hepworth G; Ignatiadis S; Dharan A; Carne R; Seneviratne U; Cook MJ; D'Souza WJ
    Epilepsy Behav; 2020 Mar; 104(Pt A):106883. PubMed ID: 32045874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety.
    Lagae L; Villanueva V; Meador KJ; Bagul M; Laurenza A; Kumar D; Yang H
    Epilepsia; 2016 Jul; 57(7):1120-9. PubMed ID: 27221398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis.
    Glauser T; Laurenza A; Yang H; Williams B; Ma T; Fain R
    Epilepsy Res; 2016 Jan; 119():34-40. PubMed ID: 26656783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy.
    Arai Y; Inaji M; Shimizu K; Kondo S; Hashimoto-Fujimoto S; Kiyokawa J; Kawano Y; Yamamoto S; Maehara T
    Epilepsy Res; 2024 Feb; 200():107307. PubMed ID: 38286107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice.
    Lattanzi S; Cagnetti C; Foschi N; Ciuffini R; Osanni E; Chiesa V; Dainese F; Dono F; Canevini MP; Evangelista G; Paladin F; Bartolini E; Ranzato F; Nilo A; Pauletto G; Marino D; Rosati E; Bonanni P; Marrelli A
    Drugs Aging; 2021 Jul; 38(7):603-610. PubMed ID: 34075567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.